Abrupt discontinuation deprescribing vs continued use
Adverse drug withdrawal events ‐ relapse (endoscopic findings) · people with mild to moderate esophagitis, symptomatic, aged > 18 years (mean age 73 years)
It is very uncertain whether abrupt discontinuation deprescribing changes adverse drug withdrawal events ‐ relapse (endoscopic findings) compared with continued use (very low certainty).
1 finding from 1 review
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults 2017 · Cochrane Headline outcomes onlyRR 3.41 [1.91, 6.09]1 study · 105 participantsVery low